A simple phone call may help millions with diabetes manage insulin — a trial puts it to the test

NCT ID NCT07729501

First seen Jul 27, 2026 · Last updated Jul 29, 2026 · Updated 2 times

Summary

This trial tests whether a multilingual interactive voice response (IVR) system can help adults with type 2 diabetes and low health literacy adjust their insulin doses. Participants use a feature phone to report blood sugar levels and receive algorithm-guided dose recommendations, reviewed by clinical staff. The study compares this approach to standard clinic-based insulin titration over 12 weeks, measuring changes in blood sugar control.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
multilingual interactive voice response (IVR) system for insulin dose adjustment
What this could lead to
If it works, this could offer a simple, phone-based way for people with low health literacy to manage insulin dosing at home, improving blood sugar control.
What could go wrong
The trial is small (220 participants) and short (12 weeks), so results may not apply to broader populations or longer-term outcomes. The system still requires human review, so it is not fully automated.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERGLYCEMIA DUE TO TYPE 2 DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Shifa Hospital

    Lahore, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.